These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27661132)

  • 1. Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity.
    Ait-Oudhia S; Ovacik MA; Mager DE
    MAbs; 2017 Jan; 9(1):15-28. PubMed ID: 27661132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
    Ayyar VS; Jusko WJ
    Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody-Drug Conjugates.
    Li C; Chen SC; Chen Y; Girish S; Kaagedal M; Lu D; Lu T; Samineni D; Jin JY
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1(Suppl 1):S105-S119. PubMed ID: 33205423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of and insights from systems pharmacology models of antibody-drug conjugates.
    Lam I; Pilla Reddy V; Ball K; Arends RH; Mac Gabhann F
    CPT Pharmacometrics Syst Pharmacol; 2022 Aug; 11(8):967-990. PubMed ID: 35712824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging systems biology approaches in clinical pharmacology.
    Melas IN; Kretsos K; Alexopoulos LG
    Biopharm Drug Dispos; 2013 Dec; 34(9):477-88. PubMed ID: 23983165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving from basic toward systems pharmacodynamic models.
    Jusko WJ
    J Pharm Sci; 2013 Sep; 102(9):2930-40. PubMed ID: 23681608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetic/pharmacodynamic pipeline: translating anticancer drug pharmacology to the clinic.
    Zhou Q; Gallo JM
    AAPS J; 2011 Mar; 13(1):111-20. PubMed ID: 21246315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merging systems biology with pharmacodynamics.
    Iyengar R; Zhao S; Chung SW; Mager DE; Gallo JM
    Sci Transl Med; 2012 Mar; 4(126):126ps7. PubMed ID: 22440734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin.
    Shah DK; Haddish-Berhane N; Betts A
    J Pharmacokinet Pharmacodyn; 2012 Dec; 39(6):643-59. PubMed ID: 23151991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems pharmacology - Towards the modeling of network interactions.
    Danhof M
    Eur J Pharm Sci; 2016 Oct; 94():4-14. PubMed ID: 27131606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems pharmacology: network analysis to identify multiscale mechanisms of drug action.
    Zhao S; Iyengar R
    Annu Rev Pharmacol Toxicol; 2012; 52():505-21. PubMed ID: 22235860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.
    Singh AP; Shin YG; Shah DK
    Pharm Res; 2015 Nov; 32(11):3508-25. PubMed ID: 25666843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
    Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
    Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic models that incorporate drug-target binding kinetics.
    Daryaee F; Tonge PJ
    Curr Opin Chem Biol; 2019 Jun; 50():120-127. PubMed ID: 31030171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stepwise integrated multi-system to screen quality markers of Chinese classic prescription Qingzao Jiufei decoction on the treatment of acute lung injury by combining 'network pharmacology-metabolomics-PK/PD modeling'.
    Wang T; Lin S; Li H; Liu R; Liu Z; Xu H; Li Q; Bi K
    Phytomedicine; 2020 Nov; 78():153313. PubMed ID: 32866904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1).
    Singh AP; Shah DK
    AAPS J; 2017 Jul; 19(4):1054-1070. PubMed ID: 28374319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using pharmacokinetic/pharmacodynamic modelling in safety pharmacology to better define safety margins: a regional workshop of the Safety Pharmacology Society.
    Cavero I
    Expert Opin Drug Saf; 2007 Jul; 6(4):465-71. PubMed ID: 17688390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development.
    Geerts H; Spiros A; Roberts P; Carr R
    J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):257-65. PubMed ID: 23338980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology.
    Garralda E; Dienstmann R; Tabernero J
    Am Soc Clin Oncol Educ Book; 2017; 37():210-215. PubMed ID: 28561730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.